How to Read a Certificate of Analysis (CoA) for Research Peptides

A Certificate of Analysis (CoA) is a formal document issued by a peptide manufacturer or analytical laboratory that verifies the identity, purity, and quality of a specific batch of peptide material. For research laboratories, the CoA is the primary evidence that a peptide meets the required specifications for experimental use.

A valid CoA should contain:

• Batch or lot number: Unique identifier for the specific production batch
• Peptide name and sequence: Chemical identity confirmation
• Analytical methods: HPLC, mass spectrometry (MS), and other tests performed
• Purity data: Quantitative results from each analytical method
• Physical characteristics: Appearance, solubility, molecular weight
• Date of analysis: When the testing was performed
• Analyst signature: Qualified person who performed or reviewed the analysis

This guide explains how to interpret each section of a CoA for research-grade peptides.

High-Performance Liquid Chromatography (HPLC) is the standard analytical method for determining peptide purity. The CoA will report a purity percentage, typically ≥95%, ≥98%, or ≥99%.

What the number means:

The purity percentage represents the area-under-the-curve (AUC) of the main peptide peak as a proportion of the total chromatographic signal. For example, a purity of 98.5% means that 98.5% of the total UV absorbance detected corresponds to the target peptide.

What it does NOT mean:

• It does not guarantee 100% of the material is the target peptide
• It does not account for non-UV-absorbing impurities (e.g., salts, solvents)
• It does not confirm the peptide sequence is correct

What to look for:

• Single sharp peak: The main peak should be symmetric and well-defined
• Minimal shoulder peaks: Small peaks adjacent to the main peak may indicate deamidation or oxidation
• Baseline: A flat baseline indicates good chromatographic separation

Acceptable thresholds for research:

• ≥95%: Minimum for most in vitro research applications
• ≥98%: Standard for published research requiring reproducibility
• ≥99%: Preferred for sensitive assays (e.g., receptor binding, crystallisation)

Researchers should consider the sensitivity of their assay when selecting purity grades.

Mass spectrometry is the gold standard for confirming peptide identity. The CoA should include a mass spectrum showing the molecular weight (MW) of the peptide.

What to verify:

• Theoretical vs. observed MW: The observed mass should match the calculated theoretical mass within ±1 Da (typically ±0.5 Da for peptides <5,000 Da)
• Charge states: Multiple peaks corresponding to different charge states (+1, +2, +3, etc.) confirm the molecular weight
• No extraneous peaks: Major peaks other than the target peptide may indicate synthetic by-products

Example verification:

• Peptide: BPC-157 (15 amino acids)
• Theoretical MW: ~1,419.5 Da
• Acceptable observed range: 1,419.0–1,420.0 Da

Modified peptides:

For peptides with post-synthetic modifications (e.g., fatty-acid conjugation in Semaglutide, N-terminal acetylation in TB-500), the MS should confirm the molecular weight shift corresponding to the modification:

• Semaglutide (with C18 fatty-diacid): ~4,114 Da (vs. native GLP-1 ~3,294 Da)
• TB-500 (N-acetylated): ~4,963 Da (vs. non-acetylated ~4,921 Da)

If the MS data does not match the expected molecular weight, the peptide identity is questionable.

Beyond HPLC and MS, a comprehensive CoA should include:

1. Endotoxin Levels (LAL Test)

• What it measures: Bacterial lipopolysaccharide contamination
• Acceptable threshold: <0.5 EU/mL for cell culture applications
• Why it matters: Endotoxins can trigger inflammatory responses in cellular assays, confounding results

2. Residual Solvents

• Common solvents: Trifluoroacetic acid (TFA), acetonitrile, dimethylformamide (DMF)
• Acceptable thresholds: Typically <0.1% TFA, <0.1% acetonitrile
• Why it matters: Residual solvents can be cytotoxic or interfere with spectroscopic assays

3. Counter-Ion Content

• Common counter-ions: TFA (trifluoroacetate), acetate
• Why it matters: Counter-ions affect peptide solubility and net charge. TFA can be acidic and affect cell culture pH.

4. Amino Acid Analysis (AAA)

• What it measures: Molar ratios of constituent amino acids
• Why it matters: Confirms the correct amino acid composition and stoichiometry
• Note: Less common for routine research-grade peptides; typically required for GMP-grade materials

5. Peptide Content (Net Peptide Content)

• What it measures: The actual mass of peptide vs. total mass (including salts, water, counter-ions)
• Why it matters: Research dosing calculations should account for net peptide content, not gross weight
• Typical range: 70–95% depending on peptide size and hydrophobicity

Researchers should be cautious if a CoA shows any of the following:

1. Missing Batch Number

• A CoA without a specific batch number cannot be traced to a physical product. Every batch should have a unique identifier.

2. No Analytical Method Details

• "Purity: >95%" without specifying HPLC method, column type, or gradient is insufficient. Legitimate CoAs specify the analytical protocol.

3. No Mass Spectrometry Data

• MS identity confirmation is essential for peptide verification. A CoA without MS data is incomplete.

4. Outdated Analysis Date

• Peptide stability data is batch-specific. A CoA from a different year than the batch number may indicate the batch was not tested or the CoA was recycled.

5. No Analyst or Reviewer Signature

• Legitimate analytical laboratories require qualified personnel to sign CoAs. Digital signatures or stamps are acceptable; blank signatures are not.

6. Generic or Template CoA

• If the CoA looks like a generic template with no batch-specific data (e.g., no actual chromatogram, no MW value), it may be fraudulent.

7. Purity Claim Without Chromatogram

• A numerical purity claim without a chromatogram image or trace is unverifiable. Always request the chromatogram if not included.

Best practice: Retain the CoA for every batch used in your research. If publishing results, include the batch number and supplier in your methods section.

UK research institutions and industrial laboratories should maintain thorough documentation for regulatory compliance:

Required records:

• Original CoA for each batch (digital or physical)
• Date of receipt and storage conditions
• Reconstitution records (date, concentration, solvent batch)
• Usage logs (date, assay, researcher, volume used)
• Disposal records

Regulatory context:

• Research peptides are not medicines under the Human Medicines Regulations 2012
• They are not controlled substances under the Misuse of Drugs Act 1971 (unless specifically scheduled)
• Research institutions must comply with their own ethics review boards and institutional safety protocols
• CoA documentation supports audit readiness and reproducibility claims

Publication requirements:

Peer-reviewed journals increasingly require detailed materials and methods sections. Include:

• Supplier name and location
• Batch or lot number
• Purity grade and analytical methods
• Storage conditions and handling dates

This documentation ensures that other researchers can replicate your work and verify your materials.